Related Experiment Video
Updated: May 10, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
SDF-1-CXCR4 differentially regulates autoimmune diabetogenic T cell adhesion through ROBO1-SLIT2 interactions in mice
John D Glawe1, Eleni M Mijalis, William C Davis
1Department of Pathology, LSU Health-Shreveport, 1501 Kings Highway, Shreveport, LA 71130, USA.
Aims/Hypothesis:
We had previously reported that stromal cell-derived factor 1 (SDF-1) mediates chemorepulsion of diabetogenic T cell adhesion to islet microvascular endothelium through unknown mechanisms in NOD mice. Here we report that SDF-1-mediated chemorepulsion occurs through slit homologue (SLIT)2-roundabout, axon guidance receptor, homologue 1 (Drosophila) (ROBO1) interactions.
Methods:
C-X-C receptor (CXCR)4 and ROBO1 protein expression was measured in mouse and human T cells. Parallel plate flow chamber adhesion and detachment studies were performed to examine the molecular importance of ROBO1 and SLIT2 for SDF-1-mediated T cell chemorepulsion. Diabetogenic splenocyte transfer was performed in NOD/LtSz Rag1(-/-) mice to examine the effect of the SDF-1 mimetic CTCE-0214 on adoptive transfer of diabetes.
Results:
CXCR4 and ROBO1 protein expression was elevated in diabetic NOD/ShiLtJ T cells over time and coincided with the onset of hyperglycaemia. CXCR4 and ROBO1 expression was also increased in human type 1 diabetic T cells, with ROBO1 expression maximal at less than 1 year post diagnosis. Cell detachment studies revealed that immunoneutralisation of ROBO1 prevented SDF-1-mediated chemorepulsion of NOD T cell firm adhesion to TNFα-stimulated islet endothelial cells. SDF-1 increased NOD T cell adhesion to recombinant adhesion molecules, a phenomenon that was reversed by recombinant SLIT2. Finally, we found that an SDF-1 peptide mimetic prevented NOD T cell adhesion in vitro and significantly delayed adoptive transfer of autoimmune diabetes in vivo.
Conclusions/Interpretation:
These data reveal a novel molecular pathway, which regulates diabetogenic T cell recruitment and may be useful in modulating autoimmune diabetes.
Insights
Stromal cell-derived factor 1 (SDF-1) uses SLIT2-ROBO1 interactions to prevent diabetogenic T cells from adhering to pancreatic islet blood vessels. This pathway offers a new target for treating autoimmune diabetes.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Stromal cell-derived factor 1 (SDF-1) is known to mediate T cell chemorepulsion in NOD mice, but the underlying mechanisms remain unclear.
- Diabetogenic T cell infiltration into pancreatic islets is a key factor in the development of autoimmune diabetes.
Purpose of the Study:
- To elucidate the molecular mechanisms by which SDF-1 mediates chemorepulsion of diabetogenic T cells.
- To investigate the role of SLIT2-ROBO1 interactions in SDF-1-mediated T cell adhesion to islet endothelium.
- To evaluate the therapeutic potential of targeting this pathway for autoimmune diabetes.
Main Methods:
- Measured C-X-C receptor (CXCR)4 and ROBO1 protein expression in mouse and human T cells.
- Utilized parallel plate flow chamber adhesion and detachment assays to assess the role of ROBO1 and SLIT2.
- Employed a diabetogenic splenocyte transfer model in NOD mice to test an SDF-1 mimetic.
Main Results:
- CXCR4 and ROBO1 expression were elevated in diabetic T cells from NOD mice and humans, correlating with disease onset and progression.
- Blocking ROBO1 inhibited SDF-1-mediated T cell chemorepulsion, while SLIT2 reversed SDF-1-induced T cell adhesion.
- An SDF-1 mimetic peptide reduced T cell adhesion in vitro and delayed diabetes onset in vivo.
Conclusions:
- SDF-1-mediated chemorepulsion of diabetogenic T cells involves SLIT2-ROBO1 interactions.
- This novel pathway regulating T cell recruitment presents a potential therapeutic target for autoimmune diabetes.
More Related Videos
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction

